<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Biocryst Pharmaceuticals Inc. (BCRX) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/bcrx/</link>
<description>Every dated entry in the public record on Biocryst Pharmaceuticals Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/bcrx/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Wed, 28 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Biocryst Pharmaceuticals Inc.: short interest 26,597,263 shares at the 15 October 2026 settlement, 5.81 days to cover</title><link>https://greeksoup.ai/stocks/us/bcrx/short-interest/</link><guid isPermaLink="false">us:BCRX:short-interest:2026-10-15:3e9bae6212</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: short interest 27,494,721 shares at the 30 September 2026 settlement, 4.62 days to cover</title><link>https://greeksoup.ai/stocks/us/bcrx/short-interest/</link><guid isPermaLink="false">us:BCRX:short-interest:2026-09-30:4cc3872099</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: short interest 34,868,460 shares at the 15 September 2026 settlement, 7.29 days to cover</title><link>https://greeksoup.ai/stocks/us/bcrx/short-interest/</link><guid isPermaLink="false">us:BCRX:short-interest:2026-09-15:0f6713ebf1</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: Gilbert Cisneros (CA31) disclosed a purchase, $1,001 - $15,000, traded 10 July 2026</title><link>https://greeksoup.ai/stocks/us/bcrx/congress/</link><guid isPermaLink="false">us:BCRX:congress:2026-09-04:d2cbc8c65c</guid><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><category>House trade</category><description><![CDATA[<p>House trade. <a href="https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035190.pdf">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/congress/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: short interest 34,050,906 shares at the 31 August 2026 settlement, 14.44 days to cover</title><link>https://greeksoup.ai/stocks/us/bcrx/short-interest/</link><guid isPermaLink="false">us:BCRX:short-interest:2026-08-31:9f9ce24121</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: Schedule 13G/A filed by RA Capital Management, L.P., 6.2% of the class</title><link>https://greeksoup.ai/stocks/us/bcrx/holders/</link><guid isPermaLink="false">us:BCRX:schedule-13:2026-08-14:d036d82ed5</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/882796/000123191926000919/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: short interest 32,939,174 shares at the 14 August 2026 settlement, 7.97 days to cover</title><link>https://greeksoup.ai/stocks/us/bcrx/short-interest/</link><guid isPermaLink="false">us:BCRX:short-interest:2026-08-14:6c0c0752aa</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: Schedule 13G filed by STATE STREET CORPORATION, 6.0% of the class</title><link>https://greeksoup.ai/stocks/us/bcrx/holders/</link><guid isPermaLink="false">us:BCRX:schedule-13:2026-08-07:2841864d37</guid><pubDate>Fri, 07 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/882796/000009375126000420/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc. Q2 FY2026 results: revenue $218 million, net income $78 million</title><link>https://greeksoup.ai/stocks/us/bcrx/results/fy2026-q2/</link><guid isPermaLink="false">us:BCRX:result:2026-08-05:eaef9c2615</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0000882796&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/bcrx/filings/</link><guid isPermaLink="false">us:BCRX:filing:2026-08-05:1571b4b1d1</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/882796/000162828026053300/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc. filed S-8: form s-8</title><link>https://greeksoup.ai/stocks/us/bcrx/filings/</link><guid isPermaLink="false">us:BCRX:filing:2026-08-05:901bb70d34</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/882796/000117184326005245/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc. filed 8-K: results of operations, regulation fd disclosure</title><link>https://greeksoup.ai/stocks/us/bcrx/filings/</link><guid isPermaLink="false">us:BCRX:filing:2026-08-05:18f8417da1</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/882796/000117184326005223/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc. filed 8-K/A: exit or disposal costs</title><link>https://greeksoup.ai/stocks/us/bcrx/filings/</link><guid isPermaLink="false">us:BCRX:filing:2026-08-04:5a61684e81</guid><pubDate>Tue, 04 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/882796/000117184326005168/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Biocryst Pharmaceuticals Inc.: short interest 32,804,839 shares at the 31 July 2026 settlement, 12.43 days to cover</title><link>https://greeksoup.ai/stocks/us/bcrx/short-interest/</link><guid isPermaLink="false">us:BCRX:short-interest:2026-07-31:2ad9d9562b</guid><pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/bcrx/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
